Completed PHASE4 INTERVENTIONAL 2-arm NCT00526331

Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy

Randomized Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy

Sponsor: Edwards Lifesciences

Conditions Disorder of the Genitourinary System Esophageal Diseases Gastrointestinal Diseases Gynecologic Diseases Kidney Diseases Liver Diseases Pancreatic Diseases Prostate Cancer Spinal Disease

Interventions FloTrac Sensor Vigileo Monitor

Updated 5 times since 2017 Last updated: Dec 8, 2011 Started: Aug 31, 2007 Primary completion: Sep 30, 2008 Completion: Sep 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00526331, this PHASE4 trial focuses on Disorder of the Genitourinary System and Esophageal Diseases and remains completed. Sponsored by Edwards Lifesciences, it has been updated 5 times since 2007, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Aug 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Edwards Lifesciences
M.D. Anderson Cancer Center

Data source: M.D. Anderson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Houston, United States